Literature DB >> 2852008

Insulin-receptor phosphotyrosyl-protein phosphatases.

M J King1, G J Sale.   

Abstract

Calmodulin-dependent protein phosphatase has been proposed to be an important phosphotyrosyl-protein phosphatase. The ability of the enzyme to attack autophosphorylated insulin receptor was examined and compared with the known ability of the enzyme to act on autophosphorylated epidermal-growth-factor (EGF) receptor. Purified calmodulin-dependent protein phosphatase was shown to catalyse the complete dephosphorylation of phosphotyrosyl-(insulin receptor). When compared at similar concentrations, 32P-labelled EGF receptor was dephosphorylated at greater than 3 times the rate of 32P-labelled insulin receptor; both dephosphorylations exhibited similar dependence on metal ions and calmodulin. Native phosphotyrosyl-protein phosphatases in cell extracts were also characterized. With rat liver, heart or brain, most (75%) of the native phosphatase activity against both 32P-labelled insulin and EGF receptors was recovered in the particulate fraction of the cell, with only 25% in the soluble fraction. This subcellular distribution contrasts with results of previous studies using artificial substrates, which found most of the phosphotyrosyl-protein phosphatase activity in the soluble fraction of the cell. Properties of particulate and soluble phosphatase activity against 32P-labelled insulin and EGF receptors are reported. The contribution of calmodulin-dependent protein phosphatase activity to phosphotyrosyl-protein phosphatase activity in cell fractions was determined by utilizing the unique metal-ion dependence of calmodulin-dependent protein phosphatase. Whereas Ni2+ (1 mM) markedly activated the calmodulin-dependent protein phosphatase, it was found to inhibit potently both particulate and soluble phosphotyrosyl-protein phosphatase activity. In fractions from rat liver, brain and heart, total phosphotyrosyl-protein phosphatase activity against both 32P-labelled receptors was inhibited by 99.5 +/- 6% (mean +/- S.E.M., 30 observations) by Ni2+. Results of Ni2+ inhibition studies were confirmed by other methods. It is concluded that in cell extracts phosphotyrosyl-protein phosphatases other than calmodulin-dependent protein phosphatase are the major phosphotyrosyl-(insulin receptor) and -(EGF receptor) phosphatases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2852008      PMCID: PMC1135500          DOI: 10.1042/bj2560893

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

Review 1.  Recent progress in our understanding of the mechanism of action of insulin.

Authors:  G J Sale
Journal:  Int J Biochem       Date:  1988

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Detection of a novel mammalian protein phosphatase with activity for phosphotyrosine.

Authors:  J G Foulkes; R F Howard; A Ziemiecki
Journal:  FEBS Lett       Date:  1981-08-03       Impact factor: 4.124

4.  Selective dephosphorylation of proteins containing phosphotyrosine by alkaline phosphatases.

Authors:  G Swarup; S Cohen; D L Garbers
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

5.  Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system.

Authors:  M Kasuga; Y Zick; D L Blithe; M Crettaz; C R Kahn
Journal:  Nature       Date:  1982-08-12       Impact factor: 49.962

6.  Discovery of a Ca2+- and calmodulin-dependent protein phosphatase: probable identity with calcineurin (CaM-BP80).

Authors:  A A Stewart; T S Ingebritsen; A Manalan; C B Klee; P Cohen
Journal:  FEBS Lett       Date:  1982-01-11       Impact factor: 4.124

7.  Separation of multiple phosphotyrosyl-and phosphoseryl-protein phosphatases from chicken brain.

Authors:  J G Foulkes; E Erikson; R L Erikson
Journal:  J Biol Chem       Date:  1983-01-10       Impact factor: 5.157

8.  Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate.

Authors:  G Swarup; S Cohen; D L Garbers
Journal:  Biochem Biophys Res Commun       Date:  1982-08       Impact factor: 3.575

9.  Phosphotyrosyl-protein phosphatase. Specific inhibition by Zn.

Authors:  D L Brautigan; P Bornstein; B Gallis
Journal:  J Biol Chem       Date:  1981-07-10       Impact factor: 5.157

10.  An acid phosphatase in the plasma membranes of human astrocytoma showing marked specificity toward phosphotyrosine protein.

Authors:  J F Leis; N O Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

View more
  13 in total

Review 1.  Insulin receptor internalization and signalling.

Authors:  G M Di Guglielmo; P G Drake; P C Baass; F Authier; B I Posner; J J Bergeron
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

2.  In vivo modulation of N-myristoyltransferase activity by orthovanadate.

Authors:  M J King; S Pugazhenthi; R L Khandelwal; R K Sharma
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

3.  Nitric oxide reversibly inhibits the epidermal growth factor receptor tyrosine kinase.

Authors:  C Estrada; C Gómez; J Martín-Nieto; T De Frutos; A Jiménez; A Villalobo
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

4.  Dephosphorylation of insulin-receptor autophosphorylation sites by particulate and soluble phosphotyrosyl-protein phosphatases.

Authors:  M J King; G J Sale
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

5.  Dephosphorylation of autophosphorylated insulin and epidermal-growth-factor receptors by two major subtypes of protein-tyrosine-phosphatase from human placenta.

Authors:  P S Tappia; R P Sharma; G J Sale
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

6.  Studies on an insulin-stimulated insulin receptor serine kinase activity: separation of the kinase activity from the insulin receptor and its reconstitution back to the insulin receptor.

Authors:  K A Asamoah; P G Atkinson; W G Carter; G J Sale
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

7.  Insulin-stimulated phosphorylation of calmodulin.

Authors:  D B Sacks; H W Davis; D L Crimmins; J M McDonald
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

8.  Dephosphorylation of human insulin-like growth factor I (IGF-I) receptors by membrane-associated tyrosine phosphatases.

Authors:  P Peraldi; S Hauguel-de Mouzon; F Alengrin; E Van Obberghen
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

9.  Hyperinsulinemia induces a reversible impairment in insulin receptor function leading to diabetes in the sand rat model of non-insulin-dependent diabetes mellitus.

Authors:  H Kanety; S Moshe; E Shafrir; B Lunenfeld; A Karasik
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

10.  Site-specific dephosphorylation and deactivation of the human insulin receptor tyrosine kinase by particulate and soluble phosphotyrosyl protein phosphatases.

Authors:  M J King; R P Sharma; G J Sale
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.